The RNAi Therapeutics market was valued at USD 807.99 Million in 2022 and is expected to reach USD 1,645.76 Million by 2030, growing at a CAGR of 9.3% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.